모야모야병 시장 규모, 점유율 및 성장 분석 : 치료법별, 진단 방법별, 환자층별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Moyamoya Disease Market size was valued at USD 642.1 Million in 2024 and is poised to grow from USD 674.85 Million in 2025 to USD 1004.7 Million by 2033, growing at a CAGR of 5.1% during the forecast period (2026-2033).

The moyamoya disease market is experiencing significant growth driven by enhanced diagnostic capabilities and increased detection rates globally, leading to a higher demand for surgical interventions. This progressive cerebrovascular condition, marked by the narrowing of intracranial arteries and fragile collateral vessels, necessitates a multifaceted approach that includes diagnostics, revascularization surgeries, neurointerventional devices, and pharmacotherapy. As patients, particularly children and young adults, face serious risks like stroke and long-term disabilities, the associated clinical and economic challenges are substantial. Technological advancements, such as high-resolution imaging and minimally invasive techniques, along with increased clinical awareness, propel the uptake of advanced diagnostics and revascularization treatments. Furthermore, ongoing investment in targeted therapies and diagnostic innovations is fostering opportunities in emerging markets, enhancing care accessibility.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Moyamoya Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Moyamoya Disease Market Segments Analysis

Global moyamoya disease market is segmented by treatment type, diagnosis type, patient demographic, end-user, distribution channel and region. Based on treatment type, the market is segmented into Drugs and Pharmacological Treatment, Surgical Procedures and Others. Based on diagnosis type, the market is segmented into Magnetic Resonance Angiography, Computed Tomography Angiography, Digital Subtraction Angiography and Others. Based on patient demographic, the market is segmented into Pediatric Patients, Adult Patients and Others. Based on end-user, the market is segmented into Hospitals, Specialized Neurology Centers, Ambulatory Surgical Centers and Others. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Moyamoya Disease Market

The Global Moyamoya Disease market is driven by heightened awareness among clinicians and the public, coupled with enhanced access to diagnostic imaging, which facilitates earlier diagnosis and more consistent referrals to specialized care. As neurologists and primary care healthcare providers increasingly recognize the condition, established pathways to interventional radiology and neurosurgery are emerging, leading healthcare organizations to enhance their training and infrastructure. This expanded approach to diagnosis bolsters market growth by increasing the number of patients undergoing evaluation and treatment, subsequently driving demand for medical management, surgical revascularization, and various device-based interventions throughout diverse healthcare environments.

Restraints in the Global Moyamoya Disease Market

The Global Moyamoya Disease market faces significant challenges due to a limited number of clinicians possessing extensive expertise in diagnosing and treating the condition. This scarcity restricts access to specialized care, particularly in regions outside major academic institutions, resulting in bottlenecks in referral processes that delay necessary treatments. The lack of trained neurosurgeons and interventional specialists hampers the development of multidisciplinary care programs, leading to reduced geographical availability and limited patient throughput. Consequently, this constrained clinical capacity deters investment in essential infrastructure and technologies at smaller hospitals, ultimately hindering the broader adoption of advanced diagnostic tools, surgical procedures, and follow-up care, despite the evident clinical need.

Market Trends of the Global Moyamoya Disease Market

The global Moyamoya disease market is witnessing a notable trend driven by advancements in imaging technologies and diagnostic protocols. Enhanced imaging modalities, such as advanced angiography and functional imaging, are significantly improving early detection and diagnostic accuracy, which crucially supports personalized treatment strategies. The implementation of standardized diagnostic pathways fosters effective multidisciplinary care coordination, enabling prompt clinical decisions. Additionally, innovations in noninvasive screening methods are empowering healthcare providers to track disease progression and optimize surgical timing. This evolving landscape not only aids clinical management but also fosters collaborations in clinical research, paving the way for the development of novel therapeutic approaches worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Moyamoya Disease Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Drugs and Pharmacological Treatment
  • Calcium Channel Blockers
  • Antiplatelet Agents
  • Anticoagulants
• Surgical Procedures
  • Direct Revascularization
  • Indirect Revascularization
• Others

Global Moyamoya Disease Market Size by Diagnosis Type & CAGR (2026-2033)

• Market Overview
• Magnetic Resonance Angiography
• Computed Tomography Angiography
• Digital Subtraction Angiography
• Others

Global Moyamoya Disease Market Size by Patient Demographic & CAGR (2026-2033)

• Market Overview
• Pediatric Patients
• Adult Patients
• Others

Global Moyamoya Disease Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialized Neurology Centers
• Ambulatory Surgical Centers
• Others

Global Moyamoya Disease Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Global Moyamoya Disease Market Size & CAGR (2026-2033)

• North America (Treatment Type, Diagnosis Type, Patient Demographic, End-User, Distribution Channel)
  • US
  • Canada
• Europe (Treatment Type, Diagnosis Type, Patient Demographic, End-User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Diagnosis Type, Patient Demographic, End-User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Diagnosis Type, Patient Demographic, End-User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Diagnosis Type, Patient Demographic, End-User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (Ceremonial/Codman)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroVention (Terumo)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mizuho Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Karl Storz
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KLS Martin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesculap
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zeiss (Carl Zeiss Meditec)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations